Business Description
Nanoviricides Inc
NAICS : 325412
SIC : 2834
ISIN : US6300872032
Description
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.2 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.13 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 5 | |||||
| 3-Year EPS without NRI Growth Rate | 4.7 | |||||
| 3-Year FCF Growth Rate | 11.1 | |||||
| 3-Year Book Growth Rate | -30.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 20.46 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.85 | |||||
| 9-Day RSI | 37.59 | |||||
| 14-Day RSI | 41.09 | |||||
| 6-1 Month Momentum % | -19.76 | |||||
| 12-1 Month Momentum % | 39.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.66 | |||||
| Quick Ratio | 3.66 | |||||
| Cash Ratio | 3.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.5 | |||||
| Shareholder Yield % | -7.56 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -66.46 | |||||
| ROA % | -59.24 | |||||
| ROIC % | -104.49 | |||||
| 3-Year ROIIC % | -13.56 | |||||
| ROC (Joel Greenblatt) % | -105.97 | |||||
| ROCE % | -63.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.61 | |||||
| Price-to-Tangible-Book | 1.59 | |||||
| EV-to-EBIT | -1.62 | |||||
| EV-to-EBITDA | -1.8 | |||||
| EV-to-FCF | -2.17 | |||||
| Price-to-Net-Current-Asset-Value | 4.96 | |||||
| Price-to-Net-Cash | 5.17 | |||||
| Earnings Yield (Greenblatt) % | -61.58 | |||||
| FCF Yield % | -34.2 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nanoviricides Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.648 | ||
| Beta | 0.84 | ||
| Volatility % | 114.48 | ||
| 14-Day RSI | 41.09 | ||
| 14-Day ATR (€) | 0.050927 | ||
| 20-Day SMA (€) | 1.322 | ||
| 12-1 Month Momentum % | 39.58 | ||
| 52-Week Range (€) | 0.9 - 3.02 | ||
| Shares Outstanding (Mil) | 13.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nanoviricides Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nanoviricides Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nanoviricides Inc Frequently Asked Questions
What is Nanoviricides Inc(STU:NV3P)'s stock price today?
The current price of STU:NV3P is €1.24. The 52 week high of STU:NV3P is €3.02 and 52 week low is €0.90.
When is next earnings date of Nanoviricides Inc(STU:NV3P)?
The next earnings date of Nanoviricides Inc(STU:NV3P) is 2025-02-14 Est..
Does Nanoviricides Inc(STU:NV3P) pay dividends? If so, how much?
Nanoviricides Inc(STU:NV3P) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers